Immunotherapy for Breast Cancer Treatment
- PMID: 33724757
- PMCID: PMC8183391
- DOI: 10.29252/ibj.25.3.140
Immunotherapy for Breast Cancer Treatment
Abstract
Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts are needed to develop alternative therapies for this type of cancer. Immunotherapy, as a novel strategy in cancer treatment, has a potential in treating breast cancer patients. Although breast cancer has long been considered problematic to treat with immunotherapy, as it is immunologically "cold," numerous newer preclinical and clinical reports now recommend that immunotherapy has the capability to treat breast cancer patients. In this review, we highlight the different immunotherapy strategies in breast cancer treatment.
Keywords: Antibodies; Breast cancer; Immunotherapy.
Figures
Similar articles
-
The therapeutic potential of immunotherapy in the treatment of breast cancer: Rational strategies and recent progress.J Cell Biochem. 2023 Apr;124(4):477-494. doi: 10.1002/jcb.30402. Epub 2023 Mar 26. J Cell Biochem. 2023. PMID: 36966454 Review.
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
The increasing efficacy of breast cancer treatment.Clin Oncol (R Coll Radiol). 1997;9(5):338-42. doi: 10.1016/s0936-6555(05)80069-x. Clin Oncol (R Coll Radiol). 1997. PMID: 9368731 Review.
-
Emerging immunotherapeutic strategies for the treatment of breast cancer.Breast Cancer Res Treat. 2022 Jan;191(2):243-255. doi: 10.1007/s10549-021-06406-1. Epub 2021 Oct 30. Breast Cancer Res Treat. 2022. PMID: 34716870 Review.
-
Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer.Cancers (Basel). 2022 Nov 6;14(21):5456. doi: 10.3390/cancers14215456. Cancers (Basel). 2022. PMID: 36358874 Free PMC article. Review.
Cited by
-
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer.Mol Cancer. 2023 Jul 6;22(1):105. doi: 10.1186/s12943-023-01805-y. Mol Cancer. 2023. PMID: 37415164 Free PMC article. Review.
References
-
- Stewart BW, Wild CP. France: International agency for research on cancer world health organization (IARC) 2014. World Cancer Report 2014.
-
- Pisani P, Parkin D, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985 Implications for prevention and projections of future burden. International journal of cancer. 1993;55(6):891–903. - PubMed
-
- Parkin DM. France: International agency for research on cancer world health organization (IARC) 1997. Cancer Incidence in Five Continents.
-
- Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Pourhoseingholi A, Barzegar F, Pourhoseingholi MA. Increased trend of breast cancer mortality in Iran. Asian pacific journal of cancer prevention. 2012;13(1):367–370. - PubMed
LinkOut - more resources
Full Text Sources